review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Angelo Giovanni Icro Maremmani | Q41340617 |
P2093 | author name string | Icro Maremmani | |
Matteo Pacini | |||
P2860 | cites work | Cocaine-induced paranoia and psychosis proneness | Q28334006 |
Activation of mu opioid receptors in the nucleus raphe dorsalis blocks apomorphine-induced aggression in rats: serotonin appears not to be involved | Q28342706 | ||
Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts | Q28373528 | ||
Therapeutic Community for Drug Addicts, Long-Term Measurement of Emotional Changes | Q51323367 | ||
Methadone and cocaine | Q51678560 | ||
Lithium treatment for cocaine abusers with bipolar spectrum disorders. | Q51736051 | ||
Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis). | Q51889746 | ||
Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. | Q52065069 | ||
Adolescent depression, alcohol and drug abuse. | Q52075726 | ||
Effects of post-trial administration of naloxone and beta-endorphin on shock-induced fighting in rats. | Q52094404 | ||
The significance of alcoholism in treated opiate addicts. | Q52098070 | ||
Heterogeneity of psychiatric diagnosis in treated opiate addicts. | Q52099346 | ||
Naloxone and naltrexone in mental illness and tardive dyskinesia. | Q52100145 | ||
Alcoholism and alcohol dependence in narcotic addicts: a prospective study with a five-year follow-up. | Q52102645 | ||
A comparison of the SADS/RDC and the DSM-III. Diagnosing drug abusers. | Q52105190 | ||
Comparison of psychometric measures in psychiatric patients using heroin and other drugs | Q52116499 | ||
Cannabis-induced psychosis. | Q52122546 | ||
Chronic psychoses and addiction to morphine. | Q52191770 | ||
Alcohol use in the opiate use cycle of the heroin addict. | Q52264387 | ||
Aspects of the psychopathology and pathophysiology of addiction | Q52264496 | ||
Use of fluoxetine in heroin addiction | Q52265295 | ||
Pain Tolerance and Narcotic Addiction | Q52269738 | ||
Adolescent opiate addiction: a study of control and addict subjects. | Q52283199 | ||
Frequency of Use of Diazepam in Individuals on Probation and in Methadone Maintenance Programs: Clinical Note | Q52703784 | ||
Antagonism of cocaine highs by lithium | Q52705367 | ||
The use of tranquilizers in the treatment of mixed drug abuse | Q52716864 | ||
[Benzodiazepines and barbiturates in chronic alcoholics and opiate addicts. An epidemiological study of hospitalized addicts] | Q53044895 | ||
The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance. | Q53402431 | ||
Depression, demographic dimensions, and drug abuse. | Q53960769 | ||
Effect of acute and chronic ethanol treatment on gamma-aminobutyric acid levels and on aminooxyacetic acid-induced GABA accumulation | Q54238972 | ||
The effectiveness of the combination fluoxetine-naltrexone in bulimia nervosa. | Q54413091 | ||
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. | Q55056971 | ||
Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts' problems | Q57151178 | ||
Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation. | Q51179442 | ||
Differential control of aggression by the midbrain. | Q51235523 | ||
Opiate addiction and depression--cause or effect? | Q51243236 | ||
DSM-III personality type and dose levels in methadone maintenance patients. | Q51264411 | ||
Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. | Q51271810 | ||
Beta-endorphin--induced changes in schizophrenic and depressed patients. | Q51284693 | ||
Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone | Q51299755 | ||
Cocaine psychoses: a continuum model | Q51300015 | ||
Phoenix House. Changes in psychopathological signs of resident drug addicts. | Q51315645 | ||
Psychological adjustment--mood and personality fluctuations of long-term methadone maintenance patients. | Q51322236 | ||
Stimulant psychosis: symptom profile and acute clinical course | Q31416884 | ||
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients | Q33586360 | ||
Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes | Q33586386 | ||
The effects of clozapine on aggression and substance abuse in schizophrenic patients | Q33662417 | ||
Cannabis psychosis and acute schizophrenia. a case-control study from India | Q33679657 | ||
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence | Q34194511 | ||
Abuse of amitriptyline | Q34270855 | ||
Drug interactions of methadone with CNS-active agents | Q34503997 | ||
Gammahydroxybutyrate: an endogenous regulator of energy metabolism | Q34515877 | ||
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine | Q34746998 | ||
Significance of gamma-hydroxybutyric acid in the brain | Q35660844 | ||
Neurobiology of cocaine abuse | Q36208834 | ||
Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography | Q36412585 | ||
Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm | Q36468390 | ||
Clozapine. A novel antipsychotic agent | Q36485618 | ||
The Mechanism of Action of Novel Antipsychotic Drugs | Q36515345 | ||
Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? | Q37543722 | ||
Pharmacological treatment of substance-abusing schizophrenic patients | Q37586675 | ||
Antidepressant for substance-abusing schizophrenic patients: a minireview | Q37677771 | ||
Mood stabilizers in the treatment of substance use disorders | Q37736248 | ||
Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse | Q38084415 | ||
Substance abuse and psychosis. The strange case of opioids | Q38190519 | ||
Comparison of diazepam and oxazepam: preference, liking and extent of abuse. | Q38581234 | ||
Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse | Q39118424 | ||
Use of psychotropic drugs in treatment of methadone maintained narcotic addicts | Q39236556 | ||
Psychopathology in substance abusers: diagnosis and treatment | Q39531596 | ||
A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice | Q39680064 | ||
Alcoholism and polydrug abuse in persons on methadone maintenance | Q39787537 | ||
Psychotropic Agents in Opiate Addiction: A Brief Review | Q40082748 | ||
Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon | Q40097547 | ||
Antidepressant treatment in methadone maintenance patients | Q40515803 | ||
The relationship between substance abuse and bipolar disorder | Q40608577 | ||
The Structure of Depression in Heroin Addicts* | Q40613475 | ||
Lithium: Effects on Subjective Functioning and Morphine-Induced Euphoria | Q40747749 | ||
The Effect of Lithium Carbonate on Affect, Mood, and Personality of Normal Subjects | Q40754729 | ||
Alprazolam and benzodiazepine dependence | Q40791749 | ||
Morphine effects on maternal aggression, pup care and analgesia in mice | Q41261192 | ||
Alcohol use by heroin addicts: evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples | Q41311352 | ||
Methadone-disulfiram interaction during methadone maintenance | Q41646891 | ||
Substance abuse in schizophrenia: a review | Q41738239 | ||
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses | Q41841648 | ||
Adverse interaction between disulfiram and marijuana: a case report | Q42245957 | ||
Naltrexone-induced panic attacks | Q42544514 | ||
Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report | Q42651457 | ||
Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report | Q43248865 | ||
Affective temperaments in alcoholic patients. | Q43293934 | ||
Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin | Q43543901 | ||
Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics | Q43689890 | ||
Psychotogenic drug use and neuroleptic response | Q43713316 | ||
Alcoholism,Heroin Dependency, and Methadone Maintenance: Alternatives and Aids to Conventional Methods of Therapy | Q43937810 | ||
Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder | Q43994379 | ||
Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts | Q44295286 | ||
Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program | Q44334747 | ||
Increasing employment of opioid dependent outpatients: an intensive behavioral intervention | Q44348679 | ||
Opioid peptides within the midbrain periaqueductal gray suppress affective defense behavior in the cat. | Q44348917 | ||
Parental alcoholism in opioid addicts | Q44350998 | ||
A possible opioid receptor dysfunction in some depressive disorders | Q44353297 | ||
Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis | Q44377979 | ||
The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance | Q44457285 | ||
Regional brain acetylcholine levels in rats acutely treated with ethanol or rendered ethanol-dependent | Q44489610 | ||
Valium use and abuse by methadone maintenance clients | Q44692599 | ||
The prevalence of psychiatric disorders in patients with alcohol and other drug problems | Q44905612 | ||
Origin of leucine-enkephalin fibers and their two main afferent pathways in the bed nucleus of the stria terminalis in the rat. | Q45124017 | ||
Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study | Q45337246 | ||
Use of disulfiram for alcoholics in methadone maintenance programs. A Veterans Administration Cooperative Study | Q45337390 | ||
[Concomitant lithium and methadone treatment in a bipolar patient: a case report]. | Q45939235 | ||
Doxepin: A Useful Adjunct in the Treatment of Heroin Addicts in a Methadone Program | Q46659800 | ||
Opposed effects of hyperthymic and cyclothymic temperament in substance use disorder (heroin- or alcohol-dependent patients). | Q47874724 | ||
Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys | Q48151370 | ||
The pathways mediating affective defense and quiet biting attack behavior from the midbrain central gray of the cat: an autoradiographic study | Q48170187 | ||
Regulation of feline aggression by the bed nucleus of stria terminalis | Q48381119 | ||
High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients | Q48709433 | ||
Enkephalinergic involvement in periaqueductal gray control of hypothalamically elicited predatory attack in the cat | Q48718358 | ||
Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine | Q48833416 | ||
Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures | Q48939710 | ||
Induction of 'rage' following microinjections of glutamate into midbrain but not hypothalamus of cats | Q48942883 | ||
Plasma beta-endorphin concentrations in people with learning disability and self-injurious and/or autistic behaviour | Q50303421 | ||
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study. | Q50303850 | ||
Male and Female Drug Abusers: Social and Psychological Status 2 Years after Treatment in a Therapeutic Community | Q58293068 | ||
Probable metabolic interaction between methadone and fluvoxamine in addict patients | Q59389037 | ||
Methadone Maintenance Treatment-A Reply | Q67070205 | ||
Delayed psychosis due to L.S.D. | Q67239056 | ||
The medical safety of the combined usage of disulfiram and methadone. Pharmacological treatment for alcoholic heroin addicts | Q67442288 | ||
Naloxone-induced modulation of feline aggression elicited from midbrain periaqueductal gray | Q68079929 | ||
Chronic atypical psychosis associated with MDMA ("ecstasy") abuse | Q68323428 | ||
The Effect of Prolonged Lithium Ingestion on Morphine Actions in the Rat | Q68942028 | ||
Abusers of alcohol and narcotics: who are they? | Q69446856 | ||
Alcohol use and abuse: heavy drinking among methadone clients | Q69680988 | ||
Medical services provided to 2,394 patients at methadone programs in three states | Q69893042 | ||
Early treatment time course of depressive symptoms in opiate addicts | Q70124389 | ||
Methadone and morphine in depression [proceedings] | Q70150186 | ||
Imipramine as Treatment for Depression in Addicts | Q70254906 | ||
Suppression of attack behavior in cats by stimulation of ventral tegmental area and nucleus accumbens | Q70645879 | ||
Naloxone potentiates shock-induced aggressive behavior in mice | Q70668639 | ||
A study of SCL-90 scores of 264 methadone patients in treatment | Q70909571 | ||
beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients | Q71231658 | ||
Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence | Q71240390 | ||
Marihuana psychosis. Acute toxic psychosis associated with the use of Cannabis derivatives | Q71356052 | ||
Chronic psychosis associated with long-term psychotomimetic drug abuse | Q71459143 | ||
The peptidergic organization of the cat periaqueductal gray. I. The distribution of immunoreactive enkephalin-containing neurons and terminals | Q71668752 | ||
Is treatment for alcoholism effective in persons on methadone maintenance? | Q71756632 | ||
Effects of opiate antagonists on social and aggressive behavior of isolated mice | Q71843340 | ||
Clozapine decreases smoking in patients with chronic schizophrenia | Q71910827 | ||
Methadone dosages and therapeutic compliance during a methadone maintenance program | Q72048563 | ||
Short-term use of disulfiram with clozapine | Q72051246 | ||
Haloperidol increases smoking in patients with schizophrenia | Q72061658 | ||
Reduction of comorbid substance abuse with clozapine | Q72248875 | ||
Decreased substance use in chronically psychotic patients treated with clozapine | Q72382753 | ||
Methadone doses and psychopathological symptoms during methadone maintenance | Q72651435 | ||
Cocaine Treatment: Research and Clinical Perspectives. Proceedings of a meeting. Bethesda, Maryland, August 16-17, 1990 | Q72727930 | ||
Substance abuse and clozapine treatment | Q72808162 | ||
Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients | Q72877875 | ||
A therapeutic use of the methadone fluvoxamine drug interaction | Q73346652 | ||
Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity | Q73788948 | ||
[Prevalence of psychiatric disorders in opiate dependent patients in contact with the drug treatment system] | Q77140173 | ||
Regional distribution of met-enkephalin within the amygdaloid complex and bed nucleus of the stria terminals | Q84235613 | ||
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level | Q90458983 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | psychosis | Q170082 |
ketone | Q170744 | ||
heroin dependence | Q18558272 | ||
Psychotic Disorders | Q60164659 | ||
P304 | page(s) | 447 | |
P577 | publication date | 2019-02-03 | |
P1433 | published in | International Journal of Environmental Research and Public Health | Q6051382 |
P1476 | title | What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients | |
P478 | volume | 16 |
Search more.